Date published: 2026-5-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

MYG1 Antibody (F-5): sc-393331

5.0(1)
Write a reviewAsk a question

Datasheets
  • MYG1 Antibody (F-5) is a mouse monoclonal IgM κ MYG1 antibody, cited in 1 publications, provided at 200 µg/ml
  • specific for an epitope mapping between amino acids 162-199 within an internal region of MYG1 of human origin
  • recommended for detection of MYG1 of mouse, rat and human origin by WB, IP, IF and ELISA
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for MYG1 Antibody (F-5). This work is in progress.
Gene Editing Promo Banner

QUICK LINKS

SEE ALSO...

MYG1 Antibody (F-5) is a mouse monoclonal IgM antibody that detects MYG1 protein of mouse, rat, and human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Anti-MYG1 antibody (F-5) is available as the non-conjugated form. MYG1, also known as Melanocyte proliferating gene 1, C12orf10, Gamm1, MYG, MST024, or MSTP024, is a 376 amino acid nucleo-mitochondrial protein that plays a crucial role in cellular processes. MYG1 is primarily located in the mitochondria and nucleus, which is significant because dual localization suggests a role in coordinating mitochondrial function and nuclear gene expression, essential for maintaining cellular homeostasis and responding to stress. MYG1 is encoded by a gene located on human chromosome 12q13.13 and is expressed ubiquitously across various tissues, with highest levels found in the testis. MYG1 features a metal-dependent protein hydrolase domain and possesses a mitochondrial targeting signal in its N-terminal region, along with a Pat7-type nuclear localization signal between amino acids 33-39. MYG1 expression varies during embryonic development, indicating involvement in early developmental processes, while stable expression in adult tissues suggests a role in stress responses and potential associations with conditions such as vitiligo.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

MYG1 Antibody (F-5) References:

  1. Characterization of Trypanosoma cruzi TcRjl locus and analysis of its transcript.  |  Nepomuceno-Silva, JL., et al. 2004. Parasitology. 129: 325-33. PMID: 15471007
  2. The finished DNA sequence of human chromosome 12.  |  Scherer, SE., et al. 2006. Nature. 440: 346-51. PMID: 16541075
  3. MYG1, novel melanocyte related gene, has elevated expression in vitiligo.  |  Kingo, K., et al. 2006. J Dermatol Sci. 44: 119-22. PMID: 16996721
  4. Characterization of MYG1 gene and protein: subcellular distribution and function.  |  Philips, MA., et al. 2009. Biol Cell. 101: 361-73. PMID: 19014353
  5. Common variants in the region around Osterix are associated with bone mineral density and growth in childhood.  |  Timpson, NJ., et al. 2009. Hum Mol Genet. 18: 1510-7. PMID: 19181680
  6. Comparative proteomic analysis of an Aspergillus fumigatus mutant deficient in glucosidase I (AfCwh41).  |  Zhang, L., et al. 2009. Microbiology (Reading). 155: 2157-2167. PMID: 19389762
  7. Myg1-deficient mice display alterations in stress-induced responses and reduction of sex-dependent behavioural differences.  |  Philips, MA., et al. 2010. Behav Brain Res. 207: 182-95. PMID: 19818808
  8. Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1.  |  Philips, MA., et al. 2010. BMC Med Genet. 11: 56. PMID: 20377893
  9. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.  |  Spritz, RA. 2010. Thyroid. 20: 745-54. PMID: 20578892

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

MYG1 Antibody (F-5)

sc-393331
200 µg/ml
$322.00

MYG1 (F-5) Neutralizing Peptide

sc-393331 P
100 µg/0.5 ml
$69.00

What application is the blocking peptide sc-393331 P appropriate for?

Asked by: DefinitelyNotMatt
Thank you for your question. The blocking peptide is intended for use as a negative control, by pre-adsorbing the mouse monoclonal antibody against the antigen. For full protocol details, please contact our Technical Services Department or view our online protocol here: https://www.scbt.com/scbt/resources/protocols/peptide-neutralization
Answered by: Technical Support
Date published: 2017-02-28
  • y_2026, m_5, d_11, h_10CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_en_US, sid_393331, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getContent, 104ms
  • QUESTIONS, PRODUCT
Rated 5 out of 5 by from Produced positive Western blot data of MYG1Produced positive Western blot data of MYG1 expression in NTERA-2 cl.D1 whole cell lysate and human tonsil tissue extract . -SCBT QC
Date published: 2013-01-17
  • y_2026, m_5, d_11, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_393331, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getReviews, 15ms
  • REVIEWS, PRODUCT
MYG1 Antibody (F-5) is rated 5.0 out of 5 by 1.
  • y_2026, m_5, d_11, h_10
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.43
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_393331, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-4.0.0
  • CLOUD, getAggregateRating, 114ms
  • REVIEWS, PRODUCT